This program will showcase best practices and insights from Sunnybrook Health Sciences Centre experts in Toronto on how to overcome barriers to early intervention and establish new treatment protocols through a case-based, tumour board format.
Scientific Committee
Dr. Kevin Higgins
Chair, MSc, FRCSC
Dr. Peter Howard
BSc, MD, FRCPC
Dr. Daniel Khalaf
MD, FRCPC
Dr. Ian Poon
MD, FRCPC
Dr. Tra Truong
BSc, MD, FRCPC
Learning Objectives
After attending the workshop, otolaryngologists will:
01
Analyze recent clinical trial data and real-world evidence to determine optimal treatments for newly diagnosed head and neck cancer patients in the Canadian healthcare context
02
Implement evidence-based multidisciplinary collaboration strategies that integrate surgical, medical oncology, radiation oncology, and pathology expertise to reduce delays in diagnosis and intervention and optimize patient outcomes
03
Evaluate biomarker-driven patient selection criteria to determine when emerging treatments should be used and when conventional approaches remain optimal, based on current evidence and patient factors
04
Apply evidence-based decision-making frameworks to integrate new therapeutic options into Canadian head and neck cancer care pathways